Article Details

First look at Verve study data offer base editing 'proof of principle' | BioPharma Dive

Retrieved on: 2023-11-12 20:42:47

Tags for this article:

Click the tags to see associated articles and topics

First look at Verve study data offer base editing 'proof of principle' | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/verve-aha-base-editing-first-data-pcsk9-cholesterol/699507/

Excerpt

Early clinical trial results showed Verve's therapy can substantially lower cholesterol levels by editing the genes of liver cells. Published Nov.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up